| CTRI Number |
CTRI/2024/11/076385 [Registered on: 08/11/2024] Trial Registered Prospectively |
| Last Modified On: |
28/02/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device Physiotherapy (Not Including YOGA) Other (Specify) [PEMF based medical device for therapeutic effect among Knee OA patients ] |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
A clinical trial to study the effect of an appropriate pulsed electromagnetic field on knee pain, functionality, and cartilage (if any) in patients suffering from osteoarthritis |
|
Scientific Title of Study
|
To establish manufacturing lines and to perform a pivotal clinical study of a Pulsed Electromagnetic Field based biophysically stimulated orthotic system for persons with knee osteoarthritis |
| Trial Acronym |
NILL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Jagannatha Sahoo |
| Designation |
Professor and Head of Department, Physical Medicine and Rehabilitation, AIIMS Bhubaneswar |
| Affiliation |
All India Institute of Medical Sciences (AIIMS), Bhubaneswar |
| Address |
Department of Physical medicine and Rehabilitation AIIMS
Bhubaneswar
Khordha
ORISSA
India
Khordha ORISSA 751019 India |
| Phone |
9437081814 |
| Fax |
|
| Email |
pmr_jagannath@aiimsbhubaneswar.edu.in |
|
Details of Contact Person Scientific Query
|
| Name |
Pooja Kumari Jha |
| Designation |
Founder and CEO |
| Affiliation |
Swayogya Rehab Solutions Pvt Ltd |
| Address |
Room No. 206(C), Campus 11, School of Chemical Technology, Kalinga Institute of Industrial
Technology (KIIT) -Technology Business Incubator (TBI),
Bhubaneswar, Orissa
Khordha ORISSA 751024 India |
| Phone |
9310207675 |
| Fax |
|
| Email |
swayogya19@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Pooja Kumari Jha |
| Designation |
Founder and CEO |
| Affiliation |
Swayogya Rehab Solutions Pvt Ltd |
| Address |
Room No. 206(C), Campus 11, School of Chemical Technology, Kalinga Institute of Industrial
Technology (KIIT) -Technology Business Incubator (TBI),
Bhubaneswar, Orissa
Khordha ORISSA 751024 India |
| Phone |
9310207675 |
| Fax |
|
| Email |
swayogya19@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Bio Technology, BIRAC, Okhla Phase III, Okhla Industrial Estate, New Delhi, Delhi 110020, India |
|
|
Primary Sponsor
|
| Name |
Swayogya Rehab Solutions Pvt Ltd |
| Address |
Room No 206(C), Campus 11, School of Chemical Technology, Kalinga Institute of Industrial Technology (KIIT),
University, KIIT-TBI, Bhubaneswar, Odisha |
| Type of Sponsor |
Other [Swayogya Rehab is an Indian med tech start up funded by DBT BIRAC, DTS etc ] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Jagannatha Sahoo |
All India Institute of Medical Sciences (AIIMS), Bhubaneswar |
Department of Physical
Medicine and
Rehabilitation, Near
Emergency, AIIMS
Bhubaneswar, Sijua,
Patrapada,
Bhubaneswar Khordha ORISSA |
9437081814
pmr_jagannath@aiimsbhubaneswar.edu.in |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 3 |
| Name of Committee |
Approval Status |
| IEC, Aatman Hospital, Bopal, Ahmedabad |
Submittted/Under Review |
| Institutional Ethics Committee, AIIMS Bhubaneswar |
Approved |
| Rajiv Gandhi Institute of Medical Sciences Srikakulam, Andhra Pradesh |
Submittted/Under Review |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M170||Bilateral primary osteoarthritis of knee, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Proposed PEMF based Medical Device |
Intervention: Biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy
Comparator/Control: No PEMF device (standard care)
The study aims to evaluate the effect of the biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy on patients with osteoarthritis (OA) by dividing participants into two groups: an experimental group and a control group. The experimental group will receive PEMF therapy with the knee orthosis for 45 minutes daily over a period of two months, while the control group will receive standard care without the PEMF device. The effects of the therapy will be assessed on the 1st, 5th, 15th, 30th, 45th, and 60th days of treatment, including an evaluation of knee sound signals (vibroarthrography) to analyze changes in joint function. |
| Comparator Agent |
Proposed PEMF based Medical Device |
Intervention: Biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy
Comparator/Control: No PEMF device (standard care)
The study aims to evaluate the effect of the biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy on patients with osteoarthritis (OA) by dividing participants into two groups: an experimental group and a control group. The experimental group will receive PEMF therapy with the knee orthosis for 45 minutes daily over a period of two months, while the control group will receive standard care without the PEMF device. The effects of the therapy will be assessed on the 1st, 5th, 15th, 30th, 45th, and 60th days of treatment, including an evaluation of knee sound signals (vibroarthrography) to analyze changes in joint function. |
|
|
Inclusion Criteria
|
| Age From |
40.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1) Primary OA Kellgren Lawrence Grade 1 -3 osteoarthritic patients.
2) Both male and female
3) Age 40-70 years
4) symptomatic disease for at least 6 months prior to enrolment
5) persistent pain despite receiving the maximal tolerated doses of conventional medical therapy |
|
| ExclusionCriteria |
| Details |
1) Persons fitted with pacemaker.
2) Any prior knee surgery.
3) Persons fitted with any metallic implants.
4) Osteoarthritic patients having Kellgren Lawrence grade as 4.
5) Persons who do not provide consent for participation.
6) Presence of any medical condition that can impart effect on proposed intervention. |
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Double Blind Double Dummy |
|
Primary Outcome
|
| Outcome |
TimePoints |
Both pre and post data related to pain and functionality from each and individual subjects on 1st, 5th, 15th, 30th, 45th and 60th day will be recorded using following methodologies in the experimental group (i.e., various data before and after the application of proposed medical device will be monitored):
a. Pain Monitoring using Visual Analogue Scale (VAS) and Pain Pressure Threshold (PPT) device
b. Functionality Monitoring using Knee Injury and Osteoarthritis Outcome Score (KOOS) and joint Angular movement measurement using Goniometers.
c. Patient life style measurement using KOOS.
d. Effect of Proposed PEMF device (i.e.Swaknee) on Knee Sound signals (Vibroarthrography)
e. Effect of proposed device on articular (if any) using MRI |
The proposed PEMF-based medical device will be applied daily to each patient in the experimental group for 45 minutes over a period of 45 days. The effects of the therapy will be assessed on the 1st, 5th, 15th, 30th, 45th, and 60th days. After completing the two-month treatment, patients will be monitored with follow-up assessments for an additional 4 months.
Knee sound signals will also be collected to evaluate any changes in joint function related to the PEMF therapy. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To monitor the effect on articular cartilage |
6 months |
|
|
Target Sample Size
|
Total Sample Size="150" Sample Size from India="150"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
25/11/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
1. Title: To check the effect of Biophysically stimulated knee orthosis on pain, functionality and articular cartilage in persons with knee osteoarthritis.
1. Background: Articular cartilage is a complex tissue that lines the joint articular surface to promote frictionless movements. It allows the joints to withstand action reaction forces generated during activities of daily living. But, when these forces fall abruptly on joint during various activities, it stimulates cartilage degeneration process. Unlike other tissues, articular cartilage is avascular in nature and lacks self -healing capability. If the cartilage degeneration process is not medically intervened at its early stages, it may lead to complete damage of the cartilage and its associated joint. Several studies have reported that the primary and secondary stages of cartilage degeneration process show symptoms of severe pain and reduced functionality of the associated joint. In many cases, the affected patients need to go for complete joint replacement surgeries at an early stage itself. This puts them under lots of burden owing to the surgery’s pain, its associated side effects, expenses and restricted functionality. If this problem remains unsolved it will further create a lot of social and financial burden to the individual and to a nation as whole.
As far as the current treatment regimens of the cartilage degenerations are concerned, they only focus on controlling inflammations in soft tissues and its associated symptoms. None of the existing medical interventions could regenerate the cartilage. Additionally, there are no techniques available for real time monitoring of the cartilage degeneration at earlier stages. Hence, now it’s a high time to come up with a technology that can address some of the issues mentioned above.
Biophysics is the study of biological systems and biological processes using physics-based methods or based on physical principles. In biophysical stimulation (for example using PEMF) a physical stimulus triggers a biological response by regulating specific intracellular pathways, thus acting as a drug. The device which provides this electric stimulation is known as a biophysically stimulating device. The efficacy of such an electrical stimulus, however, depends on the specific features of its physical wave, i.e. frequency and amplitude- and on the exposure time. In joint biophysics, the use of such biophysical stimulation (i.e PEMF-therapy) plays a central role since several preclinical and clinical studies have reported positive effects of PEMFs on pain, functionality, articular cartilage, subchondral bone and synovium. A biophysically stimulated PEMF device acts by producing a magnetic field that, in turn, induces currents to flow in nearby tissues. These induced currents mimic the natural electrical activities created within bones during movements, thus triggering a cascade of activities, from the cell membrane to the nucleus and on to the gene level, where specific changes take place. It is seen that the application of suitable PEMF parameters results in increased cytosolic calcium concentration and regulates the calcium-calmodulin pathway. In human chondrocytes (T/C-28a cells), PEMFs also acts by activating and upregulating the adenosine receptors, mainly the A2A and A3 subtypes, thus leading to an anti-inflammatory effect. This is an interesting biologic effect that could explicate the efficacy of PEMFs in reducing articular inflammation. Therefore, in this proposal, we are proposing a non- invasive and an extremely portable biophysically stimulated electronic device having both therapeutic and monitoring features to slow down and to track down the cartilage health from early to advance stages.
- Aims & Objective: i. Primary: To check the effect of Biophysically stimulated orthosis on pain and functionality in persons with knee osteoarthritis. ii. Secondary: To check the effect of Biophysically stimulated orthosis on articular cartilage in persons with knee osteoarthritis
- 3. Research questions and Hypothesis:
Research Questions:
- i. Is there any significant reduction in pain after application of biophysically stimulated knee orthosis in persons with knee osteoarthritis?
- ii. Is there any significant improvement in functionality after application of biophysically stimulated knee orthosis in persons with knee osteoarthritis?
- iii. Is there any significant effect on the articular cartilage after application of biophysically stimulated knee orthosis in persons with knee osteoarthritis?
Experimental Hypothesis:
- i. Biophysically stimulated orthosis will reduce the pain in persons with knee osteoarthritis.
- ii. Biophysically stimulated orthosis will improve the functionality in persons with knee osteoarthritis.
- iii. Biophysically stimulated orthosis will impart positive effect on articular cartilage in persons with knee osteoarthritis.
4. Materials and Methods
i. Only humans are involved in this research, animals are not included for this study.
ii. Randomized controlled trials will be used in the study.
Inclusion criteria:
- i. Primary OA Kellgren Lawrence Grade 1 -3 osteoarthritic patients.
- ii. Both male and female
- iii. Age 40-70 years
- iv. symptomatic disease for at least 6 months prior to enrolment
- v. persistent pain despite receiving the maximal tolerated doses of conventional medical therapy
Exclusion criteria:
- i. Persons fitted with pacemaker.
- ii. Any prior knee surgery.
- iii. Persons fitted with any metallic implants.
- iv. Osteoarthritic patients having Kellgren Lawrence grade as 4.
- v. Persons who do not provide consent for participation.
- vi. Presence of any medical condition that can impart effect on proposed intervention.
Sample Size calculations:
Sample size in each group and sample size determination methods: Total sample size of 42 where 21 in experimental group and 21 in control group: -
Sample size calculation is based on research entitled “Pulsed Electromagnetic fields 1h knee osteoarthritis a double blind, placebo controlled, randomized clinical trial†by Gian Luca Bagnato et.al. The pain (VAS) was taken as reference variable at end point. Assuming a pooled SD of 15.51 units, the new would require a sample size of 21 for each group. (i.e total sample size of 42 assuming each group size) to achieve a power of 80%and level of significance of 5% (two sided) for detecting a true difference in mean between the test cases and the reference group (control) of 13.6 units.
Formula used:
The sample size,
N= ((Zα/2 + Zβ)2 x 2 x σ2)/ d2 ≈ 21
Zα/2 = 1.96 (α = 0.05, confidence level)
Zβ = 0.84 (β = 0.20, power in 80%)
σ2 = population variance = [15.5 unit = σ]
d = difference in mean (d = 13.6)
5. Procedure:
i. Subjects’ will be recruited based on inclusion and exclusion criteria.
ii. Recruited subjects will be introduced to the study
iii. Consent form from each and individual patient will be collected.
iv. Randomization of the recruited subjects into control and experimental group will be done
v. Both pre and post data related to pain and functionality from each and individual subjects on 1st, 5th, 15th, 30th, 45th and 60th day will be recorded using following methodologies in the experimental group (i.e., various data before and after the application of proposed medical device will be monitored): (a). Pain Monitoring using Visual Analogue Scale (VAS) and Pain Pressure Threshold (PPT) device (b). Functionality Monitoring using Knee Injury and Osteoarthritis Outcome Score (KOOS) and joint Angular movement measurement using Goniometers. (c). Patient lifestyle measurement using KOOS. (d). Effect of proposed device on articular (if any) using MRI
vi. The same data will also be recorded from the control group without the application of the proposed medical device. vii. 90 days follow-up will be taken from the recruited patients. viii. The third party data analysis will be done |